An experimental chemo-radiation treatment is being tested in newly diagnosed cases of high-risk neuroblastoma – a deadly, hard-to-cure childhood cancer. The experimental radiopharmaceutical, 131I-MIBG, has already shown encouraging results in reducing tumor size in children with relapsed and resistant neuroblastoma. This has prompted doctors in a multi-center pilot clinical trial being led by Cincinnati Children’s